Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

219343

Sigma-Aldrich

Cathepsin S, Human, Recombinant, E. coli

Cathepsin S, Human, Recombinant, E. coli, is prepared without a tag or fusion protein. A major lysosomal cysteine proteinase with high specific activity.

Sinónimos:

Cathepsin S Protein

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Comisión internacional de enzimas:
UNSPSC Code:
12352202
NACRES:
NA.77

Quality Level

biological source

human

recombinant

expressed in E. coli

assay

≥90% (SDS-PAGE)

form

liquid

specific activity

≥30,000 mU/mg protein

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze
avoid repeated freeze/thaw cycles

technique(s)

cell based assay: suitable

Protein ID accession no.

UniProt accession no.

shipped in

wet ice

storage temp.

−70°C

Gene Information

human ... CTSS(1520)

General description

Note: 1 mU = 1 milliunit.
Research area: Cell Signaling

Recombinant, human cathepsin S expressed in E. coli without a tag or fusion protein. A major lysosomal cysteine proteinase that is preferentially expressed in macrophages and microglia. Shown to be involved in the processing of antigenic peptides for presentation by MHC Class II molecules on the surface of antigen-presenting cells by mediating invariant (Ii) chain degradation. Inhibition of cathepsin S results in impaired antigen-presentation.

Application

Cathepsin S, Human, Recombinant, E. coli has been used in cathepsin digestion reactions.

Biochem/physiol Actions

Cathepsin S is a cysteine protease that plays a role in degradation of class II complexes in human B lymphocytes. It possesses endoproteolytic activity and aids in processing and presenting antigens to immune cells, thereby influencing the immune response. Cathepsin S is involved in facilitating the degradation of damaged or unwanted proteins within the endo-lysosomal pathway. Dysregulation of Cathepsin S activity leads to the development of various diseases such as arthritis, cancer, and cardiovascular diseases.

Warning

Toxicity: Harmful (C)

Unit Definition

One unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol Z-VVR-AMC per min at 37°C, pH 6.5. Note: 1 mU = 1 milliunit.

Physical form

In 35 mM potassium phosphate, 35 mM Sodium acetate, 2 mM DTT, 2 mM EDTA, 50% ethylene glycol, pH 6.5.

Reconstitution

Following initial thaw, aliquot and freeze (-70°C).

Other Notes

Liuzzo, J.P., et al. 1999. Mol. Med.5, 334.
Riese, R.J., et al. 1998. J. Clin. Invest.101, 2351.
Sukhova, G.K., et al. 1998. J. Clin. Invest.102, 576.
Kirschke, H., and Wiederanders, B. 1994. Methods Enzymol.244, 500.
Xin, X.Q., et al. 1992. Arch. Biochem. Biophys.299, 334.
Kirschke, H., et al. 1989. Biochem. J.264, 467.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

Health hazardExclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral - STOT RE 2 Oral

target_organs

Kidney

Storage Class

10 - Combustible liquids

wgk_germany

WGK 1


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Cathepsin S: therapeutic, diagnostic, and prognostic potential
Wilkinson RDA, et al.
Biological Chemistry, 396(8), 867-882 (2015)
Cathepsin S: therapeutic, diagnostic, and prognostic potential
Wilkinson RD, et al.
Applied Biological Chemistry, 396(8), 867-882 (2015)
Cathepsin S activity regulates antigen presentation and immunity
Riese RJ, et al.
The Journal of Clinical Investigation, 101(11), 2351-2363 (1998)
Cathepsin S activity regulates antigen presentation and immunity
Riese R J, et al.
The Journal of Clinical Investigation, 2351-2363 (1998)
Xiao-Yu Yuan et al.
Bioorganic & medicinal chemistry, 27(6), 1034-1042 (2019-02-19)
Selective proteinase inhibitors have demonstrated utility in the investigation of cartilage degeneration mechanisms and may have clinical use in the management of osteoarthritis. The cysteine protease cathepsin K (CatK) is an attractive target for arthritis therapy. Here we report the

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico